Deeptech startup Leumas raises $2.2 million in funding to expand R&D capabilities

Leumas, an Indian deeptech manufacturing startup that builds next-gen, software-driven robot factories for the wellness and pharma sectors, has raised $2.2 million in a seed funding round led by Capital 2B, a deeptech-focused fund backed by Info Edge and Temasek, with participation from Capital-A and Anicut Capital. 

Leumas said the funding will be used for expanding R&D capabilities, scaling on-demand manufacturing infrastructure, and launching pilot deployments of dedicated factories for wellness and pharma brands. These asset-light and intelligent manufacturing lines support formulation development, pilot-scale production, and commercial manufacturing with greater speed, flexibility, and precision, the startup said.

“Pharma and wellness brands today need more than just capacity. They need agility, traceability, and the ability to scale without being restricted by outdated infrastructure,” said Subhajit Biswas and Nitesh K, Co-Founders of Leumas. “We are building a modern manufacturing stack that functions like software: modular, distributed, and intelligent. This funding will help us strengthen the technologies and capabilities that make on-demand manufacturing possible at scale.” 

“We invested in Leumas because they are solving a global challenge: manufacturing that is slow, expensive, and hard to scale,” said Vibhore Sharma, Partner at Capital 2B. “Their integration of advanced robotics and intelligent software, along with a delivery model that is easy for brands to adopt, makes them truly differentiated. It is a fundamental reimagining of how factories should operate today.”

“Modular, software-driven, and built to scale - this is the kind of manufacturing innovation the world needs right now,” added Ankit Kedia, Founder and Lead Investor at Capital-A. “Leumas delivers it with a rare combination of deep technical expertise and operational clarity. Their approach stands out in industries like pharma and wellness, where speed, compliance, and adaptability are essential. It’s a bold, timely solution to a global challenge and exactly the kind of vision we’re proud to support.”

Leumas offers on-demand manufacturing and factory-as-a-service models for wellness and pharma brands. The startup said that its solution is built on software-defined, modular robot factories that radically improve manufacturing and business outcomes - from development to commercial production. 

At the core of Leumas’ offering is its cyber-physical manufacturing technology: software-driven, modular production lines that integrate AI-led robotics, vision-based quality systems, and autonomous operations to ensure optimal production output and regulatory compliance. The system enables continuous, traceable manufacturing with unmanned operations, while maintaining unparalleled formulation flexibility and batch precision.

“Leumas is showing the world what the future of manufacturing looks like - modular, intelligent, and instantly scalable,” said Ajay Anand, Partner at Anicut Capital. “With India poised to become a manufacturing leader, Leumas brings the right combination of deep tech and practical execution to help brands scale efficiently.” 

Over the past year, Leumas has co-developed its manufacturing solution with leading wellness brands and has helped scale more than 120 products across India, the US, and MENA. It has also signed agreements with prominent pharma and food research institutions to build dedicated factory capacities using its modular factory solution.